Pinamonti B, Zecchin M, Di Lenarda A, Gregori D, Sinagra G, Camerini F
Department of Cardiology, University of Trieste, Italy.
J Am Coll Cardiol. 1997 Mar 1;29(3):604-12. doi: 10.1016/s0735-1097(96)00539-6.
We sought to assess the prognostic implications of the evolution of restrictive left ventricular filling pattern (RFP) in dilated cardiomyopathy (DCM).
Previous work has demonstrated that a RFP in DCM is associated with a poor prognosis. Few data are available on the prognostic implications of the evolution of this pattern.
The evolution of left ventricular filling was studied by Doppler echocardiography in 110 patients with DCM. According to the left ventricular filling pattern at presentation and after 3 months of treatment, the patients were classified into three groups: Group 1A (n = 24) had persistent restrictive filling; Group 1B (n = 29) had reversible restrictive filling; and Group 2 (n = 57) had nonrestrictive filling.
During follow-up (41 +/- 20 months), mortality plus heart transplantations was significantly higher in Group 1A than in Groups 1B and 2 (p < 0.0001). On multivariate analysis, the model incorporating E wave deceleration time at 3 months was more powerful at predicting mortality with respect to this variable at baseline (p = 0.0039). Clinical improvement at 1 and 2 years was significantly more frequent in Groups 1B and 2 than in Group 1A (p < 0.0001 at 2 years).
In patients with DCM, the persistence of restrictive filling at 3 months is associated with a high mortality and transplantation rate. The patients with reversible restrictive filling have a high probability of improvement and excellent survival. Doppler echocardiographic reevaluation of these patients after 3 months of therapy gives additional prognostic information with respect to the initial study.
我们旨在评估扩张型心肌病(DCM)中限制性左心室充盈模式(RFP)演变的预后意义。
先前的研究表明,DCM中的RFP与不良预后相关。关于这种模式演变的预后意义,可用数据很少。
通过多普勒超声心动图研究了110例DCM患者的左心室充盈演变情况。根据就诊时及治疗3个月后的左心室充盈模式,将患者分为三组:1A组(n = 24)为持续性限制性充盈;1B组(n = 29)为可逆性限制性充盈;2组(n = 57)为非限制性充盈。
在随访期间(41±20个月),1A组的死亡率加心脏移植率显著高于1B组和2组(p < 0.0001)。多变量分析显示,纳入3个月时E波减速时间的模型在预测死亡率方面比基线时该变量的预测能力更强(p = 0.0039)。1B组和2组在1年和2年时的临床改善明显比1A组更频繁(2年时p < 0.0001)。
在DCM患者中,3个月时限制性充盈持续存在与高死亡率和移植率相关。可逆性限制性充盈的患者有很高的改善可能性和良好的生存率。治疗3个月后对这些患者进行多普勒超声心动图重新评估可提供相对于初始研究的额外预后信息。